Manufacturers provide long-term data on rejected...

Manufacturers provide long-term data on rejected…

0 Comments

medicine Wednesday, July 31, 2024 Tokyo/Cambridge – The beneficial effects of the antibody lecanemab, which is approved in the USA, Japan, China, South Korea and Israel, but not in Europe, for the treatment of early